Company Filing History:
1 out of 184 
1 out of 832,880 Years Active: 2000-2004
Title: Innovations in Tumor Treatment by Jay L Stone
Introduction
Jay L Stone is a notable inventor based in Aptos, CA (US), recognized for his contributions to cancer treatment through innovative research. He holds 2 patents that focus on the tumor-killing effects of enterotoxins and superantigens. His work has significant implications for enhancing antitumor immunity and developing effective treatments for tumors.
Latest Patents
One of his latest patents discusses the tumor-killing effects of enterotoxins, superantigens, and related compounds. This patent highlights the use of superantigens, including Staphylococcal enterotoxins and streptococcal pyrogenic exotoxins, as effective agents for killing tumor cells. The treatment involves administering a tumoricidally effective amount of a superantigen to a subject with a tumor, stimulating T cells to enhance antitumor immunity. Another patent elaborates on the use of Staphylococcal enterotoxins obtained from Staphylococcus aureus, which can be utilized as tumoricidal agents in cancer treatment. These enterotoxins can be administered through intravenous injection or as adjuvants, and they may also be used ex-vivo to enrich tumoricidal T-cell populations.
Career Highlights
Throughout his career, Jay L Stone has made significant strides in the field of cancer research. His innovative approaches to utilizing biological agents for tumor treatment have positioned him as a key figure in the medical research community. His work has the potential to change the landscape of cancer therapies and improve patient outcomes.
Collaborations
Jay has collaborated with notable individuals in his field, including David Stephen Terman and David S Terman. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jay L Stone's innovative work in the field of cancer treatment through the use of enterotoxins and superantigens showcases his commitment to advancing medical science. His patents reflect a promising direction for future cancer therapies, emphasizing the importance of continued research and innovation in this critical area.